Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis

Xiao Xiao, Zhiguo Liu, Rui Wang, Jiayin Wang, Song Zhang, Xiqiang Cai, Kaichun Wu, Raymond Bergan, Li Xu, Daiming Fan

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Dietary consumption of genistein, found in soy, has been associated with a potentially protective role in colorectal cancer (CRC) development and progression. Herein we demonstrate that genistein will inhibit human CRC cell invasion and migration, that it does so at non-cytotoxic concentrations and we demonstrate this in multiple human CRC cell lines. After orthotopic implantation of human CRC tumors into mice, oral genistein did not inhibit tumor growth, but did inhibit distant metastasis formation, and was non-toxic to mice. Using a qPCR array, we screened for genistein-induced changes in gene expression, followed by Western blot confirmation, demonstrating that genistein downregulated matrix metalloproteinase 2 and Fms- Related Tyrosine Kinase 4 (FLT4; vascular endothelial growth factor receptor 3). After demonstrating that genistein suppressed neo-angiogenesis in mouse tumors, we examined FLT4 expression in primary CRC and adjacent normal colonic tissue from 60 human subjects, demonstrating that increased FLT4 significantly correlates with increased stage and decreased survival. In summary, we demonstrate for the first time that genistein inhibits human CRC metastasis at dietary, non-toxic, doses. FLT4 is identified as a marker of metastatic disease, and as a response marker for small molecule therapeutics that inhibit CRC metastasis.

Original languageEnglish (US)
Pages (from-to)3225-3239
Number of pages15
JournalOncotarget
Volume6
Issue number5
StatePublished - 2015
Externally publishedYes

Fingerprint

Genistein
Colorectal Neoplasms
Neoplasm Metastasis
Vascular Endothelial Growth Factor Receptor-3
Matrix Metalloproteinase 2
Protein-Tyrosine Kinases
Cell Movement
Neoplasms
Down-Regulation
Western Blotting
Gene Expression
Cell Line
Survival
Growth

Keywords

  • Colorectal cancer
  • FLT4
  • Genistein
  • Metastasis
  • Orthotopic mouse model

ASJC Scopus subject areas

  • Oncology

Cite this

Xiao, X., Liu, Z., Wang, R., Wang, J., Zhang, S., Cai, X., ... Fan, D. (2015). Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis. Oncotarget, 6(5), 3225-3239.

Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis. / Xiao, Xiao; Liu, Zhiguo; Wang, Rui; Wang, Jiayin; Zhang, Song; Cai, Xiqiang; Wu, Kaichun; Bergan, Raymond; Xu, Li; Fan, Daiming.

In: Oncotarget, Vol. 6, No. 5, 2015, p. 3225-3239.

Research output: Contribution to journalArticle

Xiao, X, Liu, Z, Wang, R, Wang, J, Zhang, S, Cai, X, Wu, K, Bergan, R, Xu, L & Fan, D 2015, 'Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis', Oncotarget, vol. 6, no. 5, pp. 3225-3239.
Xiao X, Liu Z, Wang R, Wang J, Zhang S, Cai X et al. Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis. Oncotarget. 2015;6(5):3225-3239.
Xiao, Xiao ; Liu, Zhiguo ; Wang, Rui ; Wang, Jiayin ; Zhang, Song ; Cai, Xiqiang ; Wu, Kaichun ; Bergan, Raymond ; Xu, Li ; Fan, Daiming. / Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis. In: Oncotarget. 2015 ; Vol. 6, No. 5. pp. 3225-3239.
@article{788dc83da50f4a9aab52ef67a6864471,
title = "Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis",
abstract = "Dietary consumption of genistein, found in soy, has been associated with a potentially protective role in colorectal cancer (CRC) development and progression. Herein we demonstrate that genistein will inhibit human CRC cell invasion and migration, that it does so at non-cytotoxic concentrations and we demonstrate this in multiple human CRC cell lines. After orthotopic implantation of human CRC tumors into mice, oral genistein did not inhibit tumor growth, but did inhibit distant metastasis formation, and was non-toxic to mice. Using a qPCR array, we screened for genistein-induced changes in gene expression, followed by Western blot confirmation, demonstrating that genistein downregulated matrix metalloproteinase 2 and Fms- Related Tyrosine Kinase 4 (FLT4; vascular endothelial growth factor receptor 3). After demonstrating that genistein suppressed neo-angiogenesis in mouse tumors, we examined FLT4 expression in primary CRC and adjacent normal colonic tissue from 60 human subjects, demonstrating that increased FLT4 significantly correlates with increased stage and decreased survival. In summary, we demonstrate for the first time that genistein inhibits human CRC metastasis at dietary, non-toxic, doses. FLT4 is identified as a marker of metastatic disease, and as a response marker for small molecule therapeutics that inhibit CRC metastasis.",
keywords = "Colorectal cancer, FLT4, Genistein, Metastasis, Orthotopic mouse model",
author = "Xiao Xiao and Zhiguo Liu and Rui Wang and Jiayin Wang and Song Zhang and Xiqiang Cai and Kaichun Wu and Raymond Bergan and Li Xu and Daiming Fan",
year = "2015",
language = "English (US)",
volume = "6",
pages = "3225--3239",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "5",

}

TY - JOUR

T1 - Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis

AU - Xiao, Xiao

AU - Liu, Zhiguo

AU - Wang, Rui

AU - Wang, Jiayin

AU - Zhang, Song

AU - Cai, Xiqiang

AU - Wu, Kaichun

AU - Bergan, Raymond

AU - Xu, Li

AU - Fan, Daiming

PY - 2015

Y1 - 2015

N2 - Dietary consumption of genistein, found in soy, has been associated with a potentially protective role in colorectal cancer (CRC) development and progression. Herein we demonstrate that genistein will inhibit human CRC cell invasion and migration, that it does so at non-cytotoxic concentrations and we demonstrate this in multiple human CRC cell lines. After orthotopic implantation of human CRC tumors into mice, oral genistein did not inhibit tumor growth, but did inhibit distant metastasis formation, and was non-toxic to mice. Using a qPCR array, we screened for genistein-induced changes in gene expression, followed by Western blot confirmation, demonstrating that genistein downregulated matrix metalloproteinase 2 and Fms- Related Tyrosine Kinase 4 (FLT4; vascular endothelial growth factor receptor 3). After demonstrating that genistein suppressed neo-angiogenesis in mouse tumors, we examined FLT4 expression in primary CRC and adjacent normal colonic tissue from 60 human subjects, demonstrating that increased FLT4 significantly correlates with increased stage and decreased survival. In summary, we demonstrate for the first time that genistein inhibits human CRC metastasis at dietary, non-toxic, doses. FLT4 is identified as a marker of metastatic disease, and as a response marker for small molecule therapeutics that inhibit CRC metastasis.

AB - Dietary consumption of genistein, found in soy, has been associated with a potentially protective role in colorectal cancer (CRC) development and progression. Herein we demonstrate that genistein will inhibit human CRC cell invasion and migration, that it does so at non-cytotoxic concentrations and we demonstrate this in multiple human CRC cell lines. After orthotopic implantation of human CRC tumors into mice, oral genistein did not inhibit tumor growth, but did inhibit distant metastasis formation, and was non-toxic to mice. Using a qPCR array, we screened for genistein-induced changes in gene expression, followed by Western blot confirmation, demonstrating that genistein downregulated matrix metalloproteinase 2 and Fms- Related Tyrosine Kinase 4 (FLT4; vascular endothelial growth factor receptor 3). After demonstrating that genistein suppressed neo-angiogenesis in mouse tumors, we examined FLT4 expression in primary CRC and adjacent normal colonic tissue from 60 human subjects, demonstrating that increased FLT4 significantly correlates with increased stage and decreased survival. In summary, we demonstrate for the first time that genistein inhibits human CRC metastasis at dietary, non-toxic, doses. FLT4 is identified as a marker of metastatic disease, and as a response marker for small molecule therapeutics that inhibit CRC metastasis.

KW - Colorectal cancer

KW - FLT4

KW - Genistein

KW - Metastasis

KW - Orthotopic mouse model

UR - http://www.scopus.com/inward/record.url?scp=84923299804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923299804&partnerID=8YFLogxK

M3 - Article

C2 - 25605009

AN - SCOPUS:84923299804

VL - 6

SP - 3225

EP - 3239

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 5

ER -